Mark A Meltz - Net Worth and Insider Trading
Mark A Meltz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark A Meltz owns 1 companies in total, including Kinnate Biopharma Inc (KNTE) .
Click here to see the complete history of Mark A Meltz’s form 4 insider trades.
Insider Ownership Summary of Mark A Meltz
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KNTE | Kinnate Biopharma Inc | 2020-12-02 | COO General Counsel Treasurer |
Mark A Meltz Trading Performance
Mark A Meltz Ownership Network
Ownership Network List of Mark A Meltz
Ownership Network Relation of Mark A Meltz
Mark A Meltz Owned Company Details
What does Kinnate Biopharma Inc do?
Who are the key executives at Kinnate Biopharma Inc?
Mark A Meltz is the COO General Counsel Treasurer of Kinnate Biopharma Inc. Other key executives at Kinnate Biopharma Inc include director & 10 percent owner James B. Tananbaum , 10 percent owner Foresite Capital Fund Iv, L.p. , and director & 10 percent owner Orbimed Capital Gp Viii Llc .
Kinnate Biopharma Inc (KNTE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kinnate Biopharma Inc (KNTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kinnate Biopharma Inc (KNTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kinnate Biopharma Inc (KNTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kinnate Biopharma Inc Insider Transactions
Mark A Meltz Mailing Address
Above is the net worth, insider trading, and ownership report for Mark A Meltz. You might contact Mark A Meltz via mailing address: C/o Audentes Therapeutics, Inc., 600 California Street, 17th Floor, San Francisco Ca 94108.